The text presents financial statements and information on sales, expenses, income, assets, and liabilities for Raytheon Technologies Corporation, as well as discussion regarding the impact of Russia sanctions and the COVID-19 pandemic on the company. It also covers details on acquisitions, dispositions, goodwill, and intangible assets, along with explanations on adjustments and uncertainties regarding the company's financial results for the quarter. Furthermore, it includes information on pension assets and liabilities, future benefit obligations, net periodic benefit expenses, income taxes, financial instruments, fair value measurements, and various obligations such as guarantees, commitments, contingencies, and performance guarantees related to the company's financial health, investments, risks, and challenges.
The text discusses a comprehensive overview of Raytheon Technologies Corporation's financial condition, results of operations, and management's discussion and analysis for the quarter ended March 31, 2022. It covers the business overview, industry considerations, impacts of the COVID-19 pandemic, and significant financial factors affecting the company. Additionally, it delves into key figures, such as net sales, operating profit, and income, across its principal business segments: Collins Aerospace Systems, Pratt & Whitney, Raytheon Intelligence & Space, and Raytheon Missiles & Defense. The document also presents detailed information on critical accounting estimates, financial metrics, including liquidity and financial condition, as well as cash flows from operating, investing, and financing activities. Furthermore, it addresses the company's debt management, share repurchases, dividends, and overall financial performance for the period in review.
There has been no notable change in the company's market risk exposure during the first quarter of 2022. For further details on their market risk exposure, refer to Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk," found in their 2021 Form 10-K.
The text provided discusses the evaluation of disclosure controls and procedures under the Securities Exchange Act of 1934, stating that as of March 31, 2022, the controls and procedures were effective. It also includes a cautionary note on forward-looking statements and factors that may affect future results, highlighting risks such as economic conditions, government sales, challenges in technology development, COVID-19 impact, legal proceedings, tax exposures, cybersecurity, and climate change considerations. The document emphasizes the importance of comprehensive risk analysis and mentions the need for ongoing monitoring and updates as necessary.
The text discusses legal proceedings and directs readers to refer to "Note 15: Commitments and Contingencies" within Item 1 of Form 10-Q for information on material legal proceedings. It states that there have been no significant developments in legal proceedings and advises readers to check the 2021 Annual Report on Form 10-K for previously reported information about legal proceedings.
The text provides a statement advising readers to review and consider certain risk factors that could impact a business, as detailed in the 2021 Annual Report on Form 10-K. It mentions that there have been no significant changes from the factors disclosed in the previous report but indicates that any modifications or additional factors will be updated in future filings with the Securities and Exchange Commission (SEC).
The text provides information on the unregistered sales of equity securities and the issuer's purchases of equity securities during the quarter ended March 31, 2022. The issuer repurchased a total of 7,883 shares at an average price of $95.91 as part of a share repurchase program authorized by the Board of Directors for up to $6 billion. The shares purchased were part of a publicly announced program, and there is still approximately $5.2 billion remaining under the program for future purchases. The repurchase program allows for various methods of acquiring shares, including open market purchases, privately negotiated transactions, and compliance with specified regulations. No shares were reacquired outside the program during the specified quarter.
I'm ready to help with the summary once you provide me with the text parts you mentioned.
I'm here to help! Please go ahead and provide me with the text that you would like me to summarize.
I'm sorry, but it seems like you have not provided any text parts for me to summarize. Could you please provide me with the text that needs to be summarized?
The text is a list of exhibits related to various financial and incentive plans of Raytheon Technologies Corporation, including restricted stock units, performance share units, stock appreciation rights, stock options, executive severance plan, and a consulting agreement. It also includes certifications, XBRL documents, and signatures of company officials. The exhibits provide details on financial statements and are formatted in Inline XBRL. The document was signed by Neil G. Mitchill, Jr., the Executive Vice President and Chief Financial Officer, and Amy L. Johnson, Corporate Vice President and Controller.
